Skip to main content

Akebia Therapeutics, Inc.

AKBA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001517022

No open-market purchases or sales by Akebia Therapeutics, Inc. insiders were filed in the last 90 days; 170 institutions reported holding it in 13F filings for Q2 2026, worth $123.2M in total; no superinvestor holds it.

13F holders, Q4 2021

Institutional positions in Akebia Therapeutics, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
133
+7 vs. Q3 2021
Shares held
96.8M
−1.66M (−1.7%) vs. Q3 2021
Total value
$218.7M
−$64.9M (−22.9%) vs. Q3 2021
New holders
28
43 more added
Sold out
21
35 more reduced

1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting AKBA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2021: 133 institutions
Q1 2021: 145 institutionsQ2 2021: 139 institutionsQ3 2021: 127 institutionsQ4 2021: 133 institutionsQ1 2022: 124 institutionsQ2 2022: 97 institutionsQ3 2022: 90 institutionsQ4 2022: 75 institutionsQ1 2023: 65 institutionsQ2 2023: 79 institutionsQ3 2023: 76 institutionsQ4 2023: 87 institutionsQ1 2024: 114 institutionsQ2 2024: 103 institutionsQ3 2024: 114 institutionsQ4 2024: 121 institutionsQ1 2025: 143 institutionsQ2 2025: 158 institutionsQ3 2025: 177 institutionsQ4 2025: 166 institutionsQ1 2026: 171 institutionsQ2 2026: 170 institutions
Value heldQ4 2021: $218.7M
Q1 2021: $340.3MQ2 2021: $402.4MQ3 2021: $283.7MQ4 2021: $218.7MQ1 2022: $58.3MQ2 2022: $20.2MQ3 2022: $16.5MQ4 2022: $30.2MQ1 2023: $29.1MQ2 2023: $46.0MQ3 2023: $58.0MQ4 2023: $72.7MQ1 2024: $104.3MQ2 2024: $57.4MQ3 2024: $78.4MQ4 2024: $128.9MQ1 2025: $182.7MQ2 2025: $394.1MQ3 2025: $337.7MQ4 2025: $190.4MQ1 2026: $141.4MQ2 2026: $123.2M
Institutions holding AKBA and their total value by quarter
QuarterHoldersValue
Q2 2026170$123.2M
Q1 2026171$141.4M
Q4 2025166$190.4M
Q3 2025177$337.7M
Q2 2025158$394.1M
Q1 2025143$182.7M
Q4 2024121$128.9M
Q3 2024114$78.4M
Q2 2024103$57.4M
Q1 2024114$104.3M
Q4 202387$72.7M
Q3 202376$58.0M
Q2 202379$46.0M
Q1 202365$29.1M
Q4 202275$30.2M
Q3 202290$16.5M
Q2 202297$20.2M
Q1 2022124$58.3M
Q4 2021133$218.7M
Q3 2021127$283.7M
Q2 2021139$402.4M
Q1 2021145$340.3M

Institutions, Q4 2021

Shares, value and share of portfolio for each institution holding Akebia Therapeutics, Inc.; share changes are against Q3 2021.

Institutions holding AKBA in Q4 2021
InstitutionSharesValue% of portfolioChange in sharesAction
HRT Financial LP378,568$855.0K0.00%+378,568New
Two Sigma Advisers, LP400,649$905.0K0.00%+37,757+10.4%Added
Connor, Clark & Lunn Investment Management Ltd.402,416$909.0K0.00%−28,255−6.6%Reduced
PDT Partners, LLC433,400$979.0K0.07%−148,300−25.5%Reduced
Charles Schwab Investment Management Inc443,958$1.00M0.00%00.0%Unchanged
Bank of America Corp459,079$1.04M0.00%+300,669+189.8%Added
UBS Group AG482,650$1.09M0.00%−46,195−8.7%Reduced
Rice Hall James & Associates, LLC486,220$1.10M0.04%−79,806−14.1%Reduced
Citadel Advisors LLC565,897$1.28M0.00%+426,399+305.7%Added
Nuveen Asset Management, LLC580,106$1.33M0.00%+7,107+1.2%Added
Renaissance Technologies LLC623,027$1.41M0.00%−326,900−34.4%Reduced
Bank of New York Mellon Corp624,845$1.41M0.00%+33,016+5.6%Added
Prudential Financial Inc630,912$1.43M0.00%−452,993−41.8%Reduced
Citigroup Inc676,186$1.53M0.00%+227,543+50.7%Added
Rafferty Asset Management, LLC738,075$1.67M0.01%+64,136+9.5%Added
Susquehanna International Group, LLP855,575$1.93M0.00%+67,362+8.5%Added
Morgan Stanley1,196,214$2.70M0.00%−277,291−18.8%Reduced
Orchard Capital Managment, LLC1,593,531$3.60M1.06%00.0%Unchanged
Northern Trust Corp1,746,054$3.95M0.00%−26,117−1.5%Reduced
Millennium Management LLC1,923,834$4.35M0.00%+1,923,834New
Federated Hermes, Inc.2,034,347$4.60M0.01%+5,244+0.3%Added
Goldman Sachs Group Inc2,147,163$4.85M0.00%+1,632,905+317.5%Added
Woodline Partners LP2,231,966$5.04M0.07%−91,551−3.9%Reduced
Dimensional Fund Advisors LP2,593,841$5.86M0.00%+498,078+23.8%Added
Jacobs Levy Equity Management, Inc2,737,900$6.19M0.04%+75,855+2.8%Added
Geode Capital Management, LLC3,207,989$7.25M0.00%−21,954−0.7%Reduced
JPMorgan Chase & Co4,432,203$10.0M0.00%−133,532−2.9%Reduced
Marshall Wace, LLP4,475,138$10.1M0.02%−2,493,673−35.8%Reduced
Satter Management Co., L.P.4,652,561$10.5M10.69%00.0%Unchanged
Nantahala Capital Management, LLC4,918,565$11.1M0.69%−59,630−1.2%Reduced
State Street Corp11,743,461$26.5M0.00%−4,112,967−25.9%Reduced
Vanguard Group Inc13,235,669$29.9M0.00%+824,426+6.6%Added
BlackRock Inc.14,124,215$31.9M0.00%+71,728+0.5%Added
PKO Investment Management Joint-Stock Co0$00.00%−622,796−100.0%Sold out
Opaleye Management Inc.0$00.00%−311,300−100.0%Sold out
Walleye Capital LLC0$00.00%−276,260−100.0%Sold out
Gsa Capital Partners LLP0$00.00%−254,376−100.0%Sold out
State of Wisconsin Investment Board0$00.00%−185,734−100.0%Sold out
Jump Financial, LLC0$00.00%−152,300−100.0%Sold out
Maverick Capital LtdSuperinvestorMaverick Capital0$00.00%−105,816−100.0%Sold out
DekaBank Deutsche Girozentrale0$00.00%−102,100−100.0%Sold out
Johnson Investment Counsel Inc0$00.00%−62,460−100.0%Sold out
Walleye Trading LLC0$00.00%−44,901−100.0%Sold out
Oxford Financial Group Ltd0$00.00%−19,006−100.0%Sold out
Kingsview Wealth Management, LLC0$00.00%−10,959−100.0%Sold out
Penserra Capital Management LLC0$00.00%−3,995−100.0%Sold out
O'Shaughnessy Asset Management, LLC0$00.00%−3,379−100.0%Sold out
Cutler Group LP0$00.00%−700−100.0%Sold out
Ellevest, Inc.0$00.00%−757−100.0%Sold out
IFP Advisors, Inc0$00.00%−152−100.0%Sold out
FMR LLC0$00.00%−37−100.0%Sold out
First Horizon Advisors, Inc.0$00.00%−63−100.0%Sold out
Gerber Kawasaki Wealth & Investment Management0$00.00%−50−100.0%Sold out
Meridian Wealth Partners, LLC0$00.00%−266−100.0%Sold out
Sonora Investment Management, LLC––––Not filed